ESC 365 - Discussion -Simple solutions to ensure efficacy in high cardiovascular risk patients.ESC 365 - Discussion -Simple solutions to ensure efficacy in high cardiovascular risk patients.
Combining beta-blockers and angiotensin-converting enzyme inhibitors in a single pill: for whom? what for? ...
https://esc365.escardio.org/presentation/179851
Disease of the smallest heart blood vessels is important global health problemDisease of the smallest heart blood vessels is important global health problem
Patients are usually treated with drugs to prevent blood clotting, such as statins, angiotensin-converting enzyme (ACE) ... inhibitors or angiotensin receptor blockers (ARBs), or drugs to dilate blood vessels such as beta-blockers, calcium channel ...
https://www.escardio.org/The-ESC/Press-Office/Press-releases/disease-of-the-smallest-heart-blood-vessels-is-important-global-health-problem
Combination therapy at the start of hypertension treatment: pros and consCombination therapy at the start of hypertension treatment: pros and cons
... angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs). Subsequent well-designed randomised ...
https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-17/combination-therapy-at-the-start-of-hypertension-treatment-pros-and-cons
Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor BlockersPosition Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers
... hypotheses have been put forward to suggest a potential adverse effects of angiotensin converting enzyme inhibitors (ACE-i) or ... Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers 13 Mar 2020 ... the COVID-19 virus binds to a specific enzyme called ACE2 to infect cells, and ACE2 levels are increased following treatment ...
https://www.escardio.org/Councils/Council-on-Hypertension-
ESC 365 - Doctor Yusuke YoshikawaESC 365 - Doctor Yusuke Yoshikawa
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range and ... Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for heart failure patients with different left ... Use or nonuse of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients hospitalized for acute ...
https://esc365.escardio.org/person/434956
ESC 365 - Direct comparison of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with acute...ESC 365 - Direct comparison of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with acute...
Use or nonuse of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients hospitalized for acute ...
https://esc365.escardio.org/presentation/158399
ESC 365 - Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the short-term prognosis of...ESC 365 - Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the short-term prognosis of...
Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the short-term prognosis of COVID-19 ... Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an ...
https://esc365.escardio.org/presentation/236815
ESC 365 - Doctor Nobuyuki EnzanESC 365 - Doctor Nobuyuki Enzan
... receptor blockers is associated with greater recovery of cardiac function than angiotensin-converting-enzyme inhibitors among ...
https://esc365.escardio.org/person/327273